Atorvastatin Calcium
Product Images NDC 53002-1335

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 53002-1335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Atorvastatin Calcium Tablets 1)

Chemical structure of atorvastatin calcium, showing the molecular arrangement including phenyl rings, hydroxyl groups, fluorine atom, and calcium ion coordination with water molecules, as related to the active ingredient atorvastatin calcium.*

FDA Label Image

Figure 1 (Atorvastatin Calcium Tablets 2)

A line graph comparing the cumulative incidence percentage over 3.5 years between Atorvastatin and placebo groups. The solid line represents Atorvastatin with a lower cumulative incidence trend than the placebo, shown by a dashed line. The graph includes statistical annotations: HR=0.64 (0.50-0.83) and p=0.0005.*

FDA Label Image

Figure 2 (Atorvastatin Calcium Tablets 3)

A cumulative hazard plot comparing Atorvastatin to Placebo over a four-year follow-up period. The x-axis represents time to first primary endpoint in years, and the y-axis shows cumulative hazard percentage. The plot includes hazard ratio (HR 0.63) and p-value (0.001), indicating statistical comparison between the two groups.*

FDA Label Image

Figure 3 (Atorvastatin Calcium Tablets 4)

A line graph comparing the percentage of subjects experiencing an event over time between two atorvastatin doses: 10 mg (dashed line) and 80 mg (solid line). The x-axis represents time in years to the first major cardiovascular endpoint, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio with confidence interval and p-value.*

FDA Label Image

Label Image (Lbl530021335)

Packaging label for Atorvastatin Calcium 20 mg tablets by RPK Pharmaceuticals, Inc. The label indicates a bottle containing 30 tablets, with directions to take one tablet daily or as directed. The label includes space for patient name and clinic information, prescription instructions, and manufacturer details.*

FDA Label Image

Label Image (Lbl530021439)

Label for Atorvastatin Calcium 10 mg tablets from RPK Pharmaceuticals, Inc. The label indicates a bottle of 100 tablets, with directions to take one tablet daily or as directed. It includes prescription use information, lot and expiration dates, barcode, and storage instructions, with generic equivalent noted as Atorvastatin 10 mg.*

FDA Label Image

Label Image (Lbl530021440)

Packaging label for Atorvastatin Calcium 40 mg tablets by RPK Pharmaceuticals, Inc. The label indicates a bottle containing 100 tablets with dosing instructions to take one tablet daily or as directed. It includes patient and prescriber information fields, barcode, lot numbers, and disposal date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.